| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| ANO2 |
anoctamin 2, calcium activated chloride channel |
12p13.3 |
1(0/1/0)
|
IEA
|
| GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
6q16.3 |
3(1/1/1)
|
IEA
|
| HSF2 |
heat shock transcription factor 2 |
6q22 |
1(1/0/0)
|
IEA
|
| DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
IEA
|
| JAM3 |
junctional adhesion molecule 3 |
11q25 |
2(1/1/0)
|
IEA
|
| GSTM1 |
glutathione S-transferase mu 1 |
1p13.3 |
1(1/0/0)
|
IPI[8373352]
|
| ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
IEA
|
| GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
1(1/0/0)
|
IDA[8493557]
|
| CIDEA |
cell death-inducing DFFA-like effector a |
18p11.21 |
1(0/0/1)
|
ISS[17080483]
|
| ADRB2 |
adrenoceptor beta 2, surface |
5q31-q32 |
1(1/0/0)
|
IDA[15123695]
|
| TP53I3 |
tumor protein p53 inducible protein 3 |
2p23.3 |
1(1/0/0)
|
IPI[19349281]
|
| P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
NAS[17895406]
|
| FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
IPI[16844695]
|
| MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
4(2/2/0)
|
IEA
|
| PTPRO |
protein tyrosine phosphatase, receptor type, O |
12p13-p12 |
1(0/1/0)
|
ISS
|
| SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
44(18/26/0)
|
IEA
|
| RABEP1 |
rabaptin, RAB GTPase binding effector protein 1 |
17p13.2 |
1(0/1/0)
|
IPI[15378032]
|
| NAMPT |
nicotinamide phosphoribosyltransferase |
7q22.3 |
1(1/0/0)
|
IEA
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
IDA[8145738]
|
| CDH13 |
cadherin 13 |
16q23.3 |
3(2/1/0)
|
IEA
|
| CPQ |
carboxypeptidase Q |
8q22.2 |
1(0/1/0)
|
IDA[12675526]
|
| ALDH9A1 |
aldehyde dehydrogenase 9 family, member A1 |
1q24.1 |
1(0/1/0)
|
IEA
|
| DST |
dystonin |
6p12.1 |
1(0/0/1)
|
IDA[19932097]
|
| TYR |
tyrosinase |
11q14.3 |
1(0/1/0)
|
ISS
|
| TRIM9 |
tripartite motif containing 9 |
14q21.3 |
1(0/1/0)
|
IPI[11331580]
|
| TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
6p12 |
1(0/1/0)
|
IPI[11505339]
|
| ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
IPI[18334220]
|
| FAM109A |
family with sequence similarity 109, member A |
12q24.12 |
1(1/0/0)
|
IPI[21233288]
|
| SRR |
serine racemase |
17p13 |
1(0/1/0)
|
IDA[15681805]; IPI[20106978]
|
| PON1 |
paraoxonase 1 |
7q21.3 |
2(2/0/0)
|
IDA[15772423]
|
| P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
NAS[17895406]
|
| IMPA2 |
inositol(myo)-1(or 4)-monophosphatase 2 |
18p11.2 |
4(2/2/0)
|
IDA[17068342]
|
| TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
ISS
|
| BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
2p16.1 |
1(1/0/0)
|
TAS[19616629]
|
| ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
21q22.3 |
1(0/1/0)
|
IDA[16870176]
|
| NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
9q22.1 |
3(1/1/1)
|
ISS
|
| S100B |
S100 calcium binding protein B |
21q22.3 |
2(1/1/0)
|
IDA[10913138]; IPI[9519411]
|
| OXCT1 |
3-oxoacid CoA transferase 1 |
5p13 |
1(1/0/0)
|
NAS[10964512]
|
| CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
5q32 |
2(1/1/0)
|
IPI[20668654]
|
| IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
8q21.1-q21.3 |
1(0/1/0)
|
IDA[17068342]
|
| HNF4A |
hepatocyte nuclear factor 4, alpha |
20q13.12 |
1(1/0/0)
|
IDA[12220494]
|
| FOXP2 |
forkhead box P2 |
7q31 |
2(0/2/0)
|
IDA[16407075]
|
| SLK |
STE20-like kinase |
10q25.1 |
1(0/0/1)
|
IDA[18239682]
|
| GSTZ1 |
glutathione S-transferase zeta 1 |
14q24.3 |
1(1/0/0)
|
IPI[10739172]
|
| TIMELESS |
timeless circadian clock |
12q13.3 |
3(0/3/0)
|
IEA
|
| PTPRE |
protein tyrosine phosphatase, receptor type, E |
10q26 |
1(1/0/0)
|
IEA
|
| ASMT |
acetylserotonin O-methyltransferase |
Xp22.3 and Yp11.3 |
1(1/0/0)
|
IPI[22775292]
|
| ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
IDA[16605244]
|
| BCL2 |
B-cell CLL/lymphoma 2 |
18q21.3 |
2(0/2/0)
|
IPI[9111042]
|
| BHLHE41 |
basic helix-loop-helix family, member e41 |
12p12.1 |
3(2/1/0)
|
ISS
|
| GCH1 |
GTP cyclohydrolase 1 |
14q22.1-q22.2 |
2(1/1/0)
|
IPI[1669853]
|
| LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
2q37.3 |
1(0/1/0)
|
IDA[23099021]
|
| DGCR8 |
DGCR8 microprocessor complex subunit |
22q11.2 |
2(1/0/1)
|
IDA[15574589]
|
| PRLR |
prolactin receptor |
5p14-p13 |
1(1/0/0)
|
NAS[10585417]
|
| CLIP1 |
CAP-GLY domain containing linker protein 1 |
12q24.3 |
1(0/1/0)
|
TAS[15928712]
|
| MYOM3 |
myomesin 3 |
1p36 |
1(0/0/1)
|
ISS
|
| TENM4 |
teneurin transmembrane protein 4 |
11q13 |
6(4/2/0)
|
ISS
|
| HLA-G |
major histocompatibility complex, class I, G |
6p21.3 |
1(1/0/0)
|
IDA[22802125]; NAS[18550825]
|
| QDPR |
quinoid dihydropteridine reductase |
4p15.31 |
1(1/0/0)
|
IEA
|
| SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
6q25.2 |
6(3/2/1)
|
ISS
|
| GSS |
glutathione synthetase |
20q11.2 |
1(0/0/1)
|
IDA[10369661]
|
| ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
IDA[16605244]
|
| ADSSL1 |
adenylosuccinate synthase like 1 |
14q32.33 |
1(0/1/0)
|
IEA
|
| ZHX2 |
zinc fingers and homeoboxes 2 |
8q24.13 |
1(0/0/1)
|
IDA[12741956]
|
| HPS4 |
Hermansky-Pudlak syndrome 4 |
22q12.1 |
1(1/0/0)
|
IPI[12663659]
|
| INHBB |
inhibin, beta B |
2q14.2 |
1(0/1/0)
|
IPI[2575216]
|
| XBP1 |
X-box binding protein 1 |
22q12.1 |
3(2/1/0)
|
TAS[22013210]
|
| HES1 |
hes family bHLH transcription factor 1 |
3q28-q29 |
1(0/1/0)
|
ISS
|
| SLC30A8 |
solute carrier family 30 (zinc transporter), member 8 |
8q24.11 |
1(1/0/0)
|
ISS
|
| HSP90AA1 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
14q32.33 |
1(1/0/0)
|
TAS[11470816]
|
| APOE |
apolipoprotein E |
19q13.31 |
1(1/0/0)
|
IPI[8245722]
|
Basic Info
